In obesity, MAT undergoes significant changes, including increased adiposity, chronic inflammation, aromatase overexpression, insulin resistance, and altered adipokine signaling, collectively fostering a pro-tumorigenic microenvironment. The gene discussed is CYP19A1; the disease is Insulin resistance.